{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:50:43Z","timestamp":1792065043126,"version":"4.4.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:00:00Z","timestamp":1792022400000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2024YFA0916800"],"award-info":[{"award-number":["2024YFA0916800"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2020YFA0908500"],"award-info":[{"award-number":["2020YFA0908500"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["2024YFC3407300"],"award-info":[{"award-number":["2024YFC3407300"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82504854"],"award-info":[{"award-number":["82504854"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404583"],"award-info":[{"award-number":["82404583"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22577090"],"award-info":[{"award-number":["22577090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Tianjin Natural Science Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77727-2","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:14:05Z","timestamp":1789384445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural and mechanistic insights into OCTN1-mediated transport and cancer cell proliferation"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0137-3381","authenticated-orcid":false,"given":"Binghong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7305-4064","authenticated-orcid":false,"given":"Shengjian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinqin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9211-2824","authenticated-orcid":false,"given":"Sai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0260-6287","authenticated-orcid":false,"given":"Cheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9300-6257","authenticated-orcid":false,"given":"Sheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2728-881X","authenticated-orcid":false,"given":"Zhiyong","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3507-3969","authenticated-orcid":false,"given":"Yaxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,14]]},"reference":[{"key":"77727_CR1","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/s0014-5793(97)01441-5","volume":"419","author":"I Tamai","year":"1997","unstructured":"Tamai, I. et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 419, 107\u2013111 https:\/\/doi.org\/10.1016\/s0014-5793(97)01441-5 (1997).","journal-title":"FEBS Lett."},{"key":"77727_CR2","doi-asserted-by":"publisher","unstructured":"Pochini, L. et al. OCTN1: A widely studied but still enigmatic organic cation transporter linked to human pathology and drug interactions. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms23020914 (2022).","DOI":"10.3390\/ijms23020914"},{"key":"77727_CR3","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1208\/s12248-014-9649-9","volume":"16","author":"JND Pereira","year":"2014","unstructured":"Pereira, J. N. D. et al. The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family. Aaps J. 16, 1247\u20131258 https:\/\/doi.org\/10.1208\/s12248-014-9649-9 (2014).","journal-title":"Aaps J."},{"key":"77727_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1177\/1087057113493006","volume":"18","author":"L Pochini","year":"2013","unstructured":"Pochini, L., Scalise, M., Galluccio, M. & Indiveri, C. OCTN Cation transporters in health and disease: role as drug targets and assay development. J. Biomol. Screen. 18, 851\u2013867 https:\/\/doi.org\/10.1177\/1087057113493006 (2013).","journal-title":"J. Biomol. Screen."},{"key":"77727_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.bbamem.2011.12.014","volume":"1818","author":"L Pochini","year":"2012","unstructured":"Pochini, L. et al. The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn\u2019s disease. Biochimica Et. Biophysica Acta-Biomembranes 1818, 559\u2013565 https:\/\/doi.org\/10.1016\/j.bbamem.2011.12.014 (2012).","journal-title":"Biochimica Et. Biophysica Acta-Biomembranes"},{"key":"77727_CR6","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.intimp.2015.04.040","volume":"29","author":"L Pochini","year":"2015","unstructured":"Pochini, L., Scalise, M. & Indiveri, C. Immuno-detection of OCTN1 (SLC22A4) in HeLa cells and characterization of transport function. Int. Immunopharmacol. 29, 21\u201326 https:\/\/doi.org\/10.1016\/j.intimp.2015.04.040 (2015).","journal-title":"Int. Immunopharmacol."},{"key":"77727_CR7","doi-asserted-by":"publisher","first-page":"5256","DOI":"10.1073\/pnas.0408624102","volume":"102","author":"D Gr\u00fcndemann","year":"2005","unstructured":"Gr\u00fcndemann, D. et al. Discovery of the ergothioneine transporter. Proc. Natl. Acad. Sci. USA 102, 5256\u20135261 https:\/\/doi.org\/10.1073\/pnas.0408624102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77727_CR8","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.bbadis.2011.09.017","volume":"1822","author":"IK Cheah","year":"2012","unstructured":"Cheah, I. K. & Halliwell, B. Ergothioneine; antioxidant potential, physiological function and role in disease. Biochimica Et. Biophysica Acta-Mol. Basis Dis. 1822, 784\u2013793 https:\/\/doi.org\/10.1016\/j.bbadis.2011.09.017 (2012).","journal-title":"Biochimica Et. Biophysica Acta-Mol. Basis Dis."},{"key":"77727_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0003-9861(91)90158-f","volume":"288","author":"D Akanmu","year":"1991","unstructured":"Akanmu, D., Cecchini, R., Aruoma, O. I. & Halliwell, B. The antioxidant action of ergothioneine. Arch. Biochem. Biophys. 288, 10\u201316 https:\/\/doi.org\/10.1016\/0003-9861(91)90158-f (1991).","journal-title":"Arch. Biochem. Biophys."},{"key":"77727_CR10","doi-asserted-by":"publisher","unstructured":"Cheah, I. K. & Halliwell, B. Ergothioneine, recent developments. Redox Biol. 42 https:\/\/doi.org\/10.1016\/j.redox.2021.101868 (2021).","DOI":"10.1016\/j.redox.2021.101868"},{"key":"77727_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/0162-0134(86)80042-3","volume":"26","author":"N Motohashi","year":"1986","unstructured":"Motohashi, N. & Mori, I. Thiol-induced hydroxyl radical formation and scavenger effect of thiocarbamides on hydroxyl radicals. J. Inorg. Biochem. 26, 205\u2013212 https:\/\/doi.org\/10.1016\/0162-0134(86)80042-3 (1986).","journal-title":"J. Inorg. Biochem."},{"key":"77727_CR12","doi-asserted-by":"publisher","unstructured":"Wen, T. T. et al. The roles and functions of ergothioneine in metabolic diseases. J. Nutr. Biochem. 141 https:\/\/doi.org\/10.1016\/j.jnutbio.2025.109895 (2025).","DOI":"10.1016\/j.jnutbio.2025.109895"},{"key":"77727_CR13","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/clpt.2013.175","volume":"94","author":"EG Geier","year":"2013","unstructured":"Geier, E. G. et al. Profiling Solute Carrier Transporters in the Human Blood-Brain Barrier. Clin. Pharmacol. Therapeutics 94, 636\u2013639 https:\/\/doi.org\/10.1038\/clpt.2013.175 (2013).","journal-title":"Clin. Pharmacol. Therapeutics"},{"key":"77727_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s12017-020-08620-4","volume":"23","author":"SS Koh","year":"2021","unstructured":"Koh, S. S. et al. Effect of Ergothioneine on 7-Ketocholesterol-Induced endothelial injury. Neuromol. Med. 23, 184\u2013198 https:\/\/doi.org\/10.1007\/s12017-020-08620-4 (2021).","journal-title":"Neuromol. Med."},{"key":"77727_CR15","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1158\/0008-5472.Can-16-2548","volume":"77","author":"CD Drenberg","year":"2017","unstructured":"Drenberg, C. D. et al. OCTN1 is a high-affinity carrier of nucleoside analogues. Cancer Res. 77, 2102\u20132111 https:\/\/doi.org\/10.1158\/0008-5472.Can-16-2548 (2017).","journal-title":"Cancer Res."},{"key":"77727_CR16","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3109\/00498254.2015.1129080","volume":"46","author":"J Zheng","year":"2016","unstructured":"Zheng, J. et al. The inhibitory effects of camptothecin (CPT) and its derivatives on the substrate uptakes mediated by human solute carrier transporters (SLCs). Xenobiotica 46, 831\u2013840 https:\/\/doi.org\/10.3109\/00498254.2015.1129080 (2016).","journal-title":"Xenobiotica"},{"key":"77727_CR17","doi-asserted-by":"publisher","unstructured":"Console, L. et al. Carnitine traffic in cells. Link with cancer. Front. Cell Develop. Biol. 8 https:\/\/doi.org\/10.3389\/fcell.2020.583850 (2020).","DOI":"10.3389\/fcell.2020.583850"},{"key":"77727_CR18","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1021\/mp0340082","volume":"1","author":"I Tamai","year":"2004","unstructured":"Tamai, I. et al. Involvement of OCTN1 SLC22A4 in pH-dependent transport of organic cations. Mol. Pharmaceutics 1, 57\u201366 https:\/\/doi.org\/10.1021\/mp0340082 (2004).","journal-title":"Mol. Pharmaceutics"},{"key":"77727_CR19","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1158\/1535-7163.Mct-08-0539","volume":"7","author":"M Okabe","year":"2008","unstructured":"Okabe, M. et al. Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters. Mol. Cancer Therapeutics 7, 3081\u20133091 https:\/\/doi.org\/10.1158\/1535-7163.Mct-08-0539 (2008).","journal-title":"Mol. Cancer Therapeutics"},{"key":"77727_CR20","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.lfs.2012.02.020","volume":"91","author":"EA Parnell","year":"2012","unstructured":"Parnell, E. A., Calleja-Macias, I. E., Kalantari, M., Grando, S. A. & Bernard, H. U. Muscarinic cholinergic signaling in cervical cancer cells affects cell motility via ERK1\/2 signaling. Life Sci. 91, 1093\u20131098 https:\/\/doi.org\/10.1016\/j.lfs.2012.02.020 (2012).","journal-title":"Life Sci."},{"key":"77727_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2174\/1570159x15666170912110450","volume":"16","author":"M Zoli","year":"2018","unstructured":"Zoli, M., Pucci, S., Vilella, A. & Gotti, C. Neuronal and extraneuronal nicotinic acetylcholine receptors. Curr. Neuropharmacol. 16, 338\u2013349 https:\/\/doi.org\/10.2174\/1570159x15666170912110450 (2018).","journal-title":"Curr. Neuropharmacol."},{"key":"77727_CR22","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.pharmthera.2018.10.002","volume":"194","author":"JR Friedman","year":"2019","unstructured":"Friedman, J. R. et al. Acetylcholine signaling system in progression of lung cancers. Pharmacol. Therapeutics 194, 222\u2013254 https:\/\/doi.org\/10.1016\/j.pharmthera.2018.10.002 (2019).","journal-title":"Pharmacol. Therapeutics"},{"key":"77727_CR23","doi-asserted-by":"publisher","first-page":"4091","DOI":"10.1007\/s13277-014-2911-z","volume":"36","author":"R Xu","year":"2015","unstructured":"Xu, R. et al. Activation of M3 muscarinic receptor by acetylcholine promotes non-small cell lung cancer cell proliferation and invasion via EGFR\/PI3K\/AKT pathway. Tumor Biol. 36, 4091\u20134100 https:\/\/doi.org\/10.1007\/s13277-014-2911-z (2015).","journal-title":"Tumor Biol."},{"key":"77727_CR24","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.suronc.2019.09.003","volume":"31","author":"JW Chen","year":"2019","unstructured":"Chen, J. W., Cheuk, I. W. Y., Shin, V. Y. & Kwong, A. Acetylcholine receptors: key players in cancer development. Surg. Oncol.-Oxf. 31, 46\u201353 https:\/\/doi.org\/10.1016\/j.suronc.2019.09.003 (2019).","journal-title":"Surg. Oncol.-Oxf."},{"key":"77727_CR25","doi-asserted-by":"publisher","unstructured":"Aronowitz, A. L., Ali, S. R., Glaun, M. D. E. & Amit, M. Acetylcholine in carcinogenesis and targeting cholinergic receptors in oncology. Adv. Biol. 6 https:\/\/doi.org\/10.1002\/adbi.202200053 (2022).","DOI":"10.1002\/adbi.202200053"},{"key":"77727_CR26","doi-asserted-by":"publisher","unstructured":"Wu, M. Y. et al. Role of non-neuronal cholinergic system in the early stage response of epithelial-mesenchymal transformation related markers in A549 cells induced by coal particles. Heliyon 8 https:\/\/doi.org\/10.1016\/j.heliyon.2022.e11751 (2022).","DOI":"10.1016\/j.heliyon.2022.e11751"},{"key":"77727_CR27","doi-asserted-by":"publisher","unstructured":"Pochini, L., Tedesco, G. E., Mazza, T., Scalise, M. & Indiveri, C. OCTN1 mediates acetylcholine transport in the A549 lung cancer cells: possible pathophysiological implications. Front. Mol. Biosci. 11 https:\/\/doi.org\/10.3389\/fmolb.2024.1512530 (2024).","DOI":"10.3389\/fmolb.2024.1512530"},{"key":"77727_CR28","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.lfs.2012.04.027","volume":"91","author":"L Pochini","year":"2012","unstructured":"Pochini, L., Scalise, M., Galluccio, M. & Indiveri, C. Regulation by physiological cations of acetylcholine transport mediated by human OCTN1 (SLC22A4). Implications in the non-neuronal cholinergic system. Life Sci. 91, 1013\u20131016 https:\/\/doi.org\/10.1016\/j.lfs.2012.04.027 (2012).","journal-title":"Life Sci."},{"key":"77727_CR29","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.bbamem.2015.12.026","volume":"1858","author":"L Pochini","year":"2016","unstructured":"Pochini, L. et al. Acetylcholine and acetylcarnitine transport in peritoneum: Role of the SLC22A4 (OCTN1) transporter. Biochimica Et. Biophysica Acta-Biomembranes 1858, 653\u2013660 https:\/\/doi.org\/10.1016\/j.bbamem.2015.12.026 (2016).","journal-title":"Biochimica Et. Biophysica Acta-Biomembranes"},{"key":"77727_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1124\/pr.118.015578","volume":"72","author":"H Koepsell","year":"2020","unstructured":"Koepsell, H. Organic Cation Transporters in Health and Disease. Pharmacol. Rev. 72, 253\u2013319 https:\/\/doi.org\/10.1124\/pr.118.015578 (2020).","journal-title":"Pharmacol. Rev."},{"key":"77727_CR31","doi-asserted-by":"publisher","unstructured":"Ferrada, E. & Superti-Furga, G. A structure and evolutionary-based classification of solute carriers. Iscience 25 https:\/\/doi.org\/10.1016\/j.isci.2022.105096 (2022).","DOI":"10.1016\/j.isci.2022.105096"},{"key":"77727_CR32","doi-asserted-by":"publisher","unstructured":"Khanppnavar, B. et al. Structural basis of organic cation transporter-3 inhibition. Nat. Commun. 13 https:\/\/doi.org\/10.1038\/s41467-022-34284-8 (2022).","DOI":"10.1038\/s41467-022-34284-8"},{"key":"77727_CR33","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s41594-023-01017-4","volume":"30","author":"Y Suo","year":"2023","unstructured":"Suo, Y. et al. Molecular basis of polyspecific drug and xenobiotic recognition by OCT1 and OCT2. Nat. Struct. Mol. Biol. 30, 1001\u20131011 https:\/\/doi.org\/10.1038\/s41594-023-01017-4 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"77727_CR34","doi-asserted-by":"publisher","unstructured":"Zeng, Y. C. et al. Structural basis of promiscuous substrate transport by Organic Cation Transporter 1. Nat. Commun. 14 https:\/\/doi.org\/10.1038\/s41467-023-42086-9 (2023).","DOI":"10.1038\/s41467-023-42086-9"},{"key":"77727_CR35","doi-asserted-by":"publisher","unstructured":"Zhang, S. et al. Structural insights into human organic cation transporter 1 transport and inhibition. Cell Discov. 10 https:\/\/doi.org\/10.1038\/s41421-024-00664-1 (2024).","DOI":"10.1038\/s41421-024-00664-1"},{"key":"77727_CR36","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1038\/s41594-023-01123-3","volume":"30","author":"T Dou","year":"2023","unstructured":"Dou, T., Lian, T., Shu, S., He, Y. & Jiang, J. The substrate and inhibitor binding mechanism of polyspecific transporter OAT1 revealed by high-resolution cryo-EM. Nat. Struct. Mol. Biol. 30, 1794\u20131805 https:\/\/doi.org\/10.1038\/s41594-023-01123-3 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"77727_CR37","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41422-024-01023-1","volume":"34","author":"Y Dai","year":"2024","unstructured":"Dai, Y. & Lee, C.-H. Transport mechanism and structural pharmacology of human urate transporter URAT1. Cell Res. 34, 776\u2013787 https:\/\/doi.org\/10.1038\/s41422-024-01023-1 (2024).","journal-title":"Cell Res."},{"key":"77727_CR38","doi-asserted-by":"publisher","unstructured":"Guo, W. et al. Mechanisms of urate transport and uricosuric drugs inhibition in human URAT1. Nat. Commun. 16 https:\/\/doi.org\/10.1038\/s41467-025-56843-5 (2025).","DOI":"10.1038\/s41467-025-56843-5"},{"key":"77727_CR39","doi-asserted-by":"publisher","unstructured":"Wu, C. et al. Molecular mechanisms of urate transport by the native human URAT1 and its inhibition by anti-gout drugs. Cell Discov. 11 https:\/\/doi.org\/10.1038\/s41421-025-00779-z (2025).","DOI":"10.1038\/s41421-025-00779-z"},{"key":"77727_CR40","doi-asserted-by":"publisher","unstructured":"Davies, J. S. et al. Structural basis of sodium ion-dependent carnitine transport by OCTN2. Nat. Commun. 17 https:\/\/doi.org\/10.1038\/s41467-025-66867-6 (2025).","DOI":"10.1038\/s41467-025-66867-6"},{"key":"77727_CR41","doi-asserted-by":"publisher","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630 https:\/\/doi.org\/10.1038\/s41586-024-07487-w (2024).","DOI":"10.1038\/s41586-024-07487-w"},{"key":"77727_CR42","doi-asserted-by":"publisher","unstructured":"Tian, X., Thorne, J. L. & Moore, J. B. Ergothioneine: an underrecognised dietary micronutrient required for healthy ageing? Br. J. Nutr. 129, 104\u2013114 https:\/\/doi.org\/10.1017\/s0007114522003592 (2023).","DOI":"10.1017\/s0007114522003592"},{"key":"77727_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbrc.2019.02.122","volume":"513","author":"RAJ Tucker","year":"2019","unstructured":"Tucker, R. A. J., Cheah, I. K. & Halliwell, B. Specificity of the ergothioneine transporter natively expressed in HeLa cells. Biochem. Biophys. Res. Commun. 513, 22\u201327 https:\/\/doi.org\/10.1016\/j.bbrc.2019.02.122 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"77727_CR44","doi-asserted-by":"publisher","first-page":"3889","DOI":"10.1007\/s11357-024-01111-5","volume":"46","author":"M Katsube","year":"2024","unstructured":"Katsube, M. et al. Ergothioneine promotes longevity and healthy aging in male mice. Geroscience 46, 3889\u20133909 https:\/\/doi.org\/10.1007\/s11357-024-01111-5 (2024).","journal-title":"Geroscience"},{"key":"77727_CR45","doi-asserted-by":"publisher","unstructured":"Petrovic, D. et al. Ergothioneine improves healthspan of aged animals by enhancing cGPDH activity through CSE-dependent persulfidation. Cell Metabol. 37 https:\/\/doi.org\/10.1016\/j.cmet.2024.12.008 (2025).","DOI":"10.1016\/j.cmet.2024.12.008"},{"key":"77727_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.freeradbiomed.2024.03.009","volume":"217","author":"B Halliwell","year":"2024","unstructured":"Halliwell, B. & Cheah, I. Are age-related neurodegenerative diseases caused by a lack of the diet-derived compound ergothioneine?. Free Radic. Biol. Med. 217, 60\u201367 https:\/\/doi.org\/10.1016\/j.freeradbiomed.2024.03.009 (2024).","journal-title":"Free Radic. Biol. Med."},{"key":"77727_CR47","doi-asserted-by":"publisher","unstructured":"Wu, L. Y. et al. Low plasma ergothioneine predicts cognitive and functional decline in an elderly cohort attending memory clinics. Antioxidants 11 https:\/\/doi.org\/10.3390\/antiox11091717 (2022).","DOI":"10.3390\/antiox11091717"},{"key":"77727_CR48","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1007\/s12033-012-9586-8","volume":"54","author":"C Indiveri","year":"2013","unstructured":"Indiveri, C., Galluccio, M., Scalise, M. & Pochini, L. Strategies of bacterial over expression of membrane transporters relevant in human health: the successful case of the three members of OCTN subfamily. Mol. Biotechnol. 54, 724\u2013736 https:\/\/doi.org\/10.1007\/s12033-012-9586-8 (2013).","journal-title":"Mol. Biotechnol."},{"key":"77727_CR49","doi-asserted-by":"publisher","first-page":"20378","DOI":"10.1074\/jbc.273.32.20378","volume":"273","author":"I Tamai","year":"1998","unstructured":"Tamai, I. et al. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2. J. Biol. Chem. 273, 20378\u201320382 https:\/\/doi.org\/10.1074\/jbc.273.32.20378 (1998).","journal-title":"J. Biol. Chem."},{"key":"77727_CR50","doi-asserted-by":"publisher","unstructured":"Zazuli, Z. et al. The impact of genetic polymorphisms in organic cation transporters on renal drug disposition. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21186627 (2020).","DOI":"10.3390\/ijms21186627"},{"key":"77727_CR51","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/01213011-200504000-00003","volume":"15","author":"T Fujita","year":"2005","unstructured":"Fujita, T. et al. Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenet. Genomics 15, 201\u2013209 https:\/\/doi.org\/10.1097\/01213011-200504000-00003 (2005).","journal-title":"Pharmacogenet. Genomics"},{"key":"77727_CR52","doi-asserted-by":"publisher","unstructured":"Galluccio, M., Tripicchio, M. & Pochini, L. The human OCTN sub-family: gene and protein structure, expression, and regulation. Int. J. Mol. Sci. 25 https:\/\/doi.org\/10.3390\/ijms25168743 (2024).","DOI":"10.3390\/ijms25168743"},{"key":"77727_CR53","doi-asserted-by":"publisher","unstructured":"Pochini, L. et al. Inflammation and organic cation transporters novel (OCTNs). Biomolecules 14 https:\/\/doi.org\/10.3390\/biom14040392 (2024).","DOI":"10.3390\/biom14040392"},{"key":"77727_CR54","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/ng1339","volume":"36","author":"VD Peltekova","year":"2004","unstructured":"Peltekova, V. D. et al. Functional variants of OCTN cation transporter genes are associated with Crohn's disease. Nat. Genet. 36, 471\u2013475 https:\/\/doi.org\/10.1038\/ng1339 (2004).","journal-title":"Nat. Genet."},{"key":"77727_CR55","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/cad.0000000000000907","volume":"31","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. Activation of muscarinic acetylcholine receptor 1 promotes invasion of hepatocellular carcinoma by inducing epithelial-mesenchymal transition. Anti-Cancer Drugs 31, 908\u2013917 https:\/\/doi.org\/10.1097\/cad.0000000000000907 (2020).","journal-title":"Anti-Cancer Drugs"},{"key":"77727_CR56","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2165\/00003495-199753050-00004","volume":"53","author":"N de Silva","year":"1997","unstructured":"de Silva, N., Guyatt, H. & Bundy, D. Anthelmintics. A comparative review of their clinical pharmacology. Drugs 53, 769\u2013788 https:\/\/doi.org\/10.2165\/00003495-199753050-00004 (1997).","journal-title":"Drugs"},{"key":"77727_CR57","doi-asserted-by":"publisher","first-page":"68571","DOI":"10.18632\/oncotarget.11851","volume":"7","author":"T Williamson","year":"2016","unstructured":"Williamson, T., Bai, R. Y., Staedtke, V., Huso, D. & Riggins, G. J. Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model. Oncotarget 7, 68571\u201368584 https:\/\/doi.org\/10.18632\/oncotarget.11851 (2016).","journal-title":"Oncotarget"},{"key":"77727_CR58","doi-asserted-by":"publisher","unstructured":"Laudisi, F., Mar\u00f4nek, M., Di Grazia, A., Monteleone, G. & Stolfi, C. Repositioning of anthelmintic drugs for the treatment of cancers of the digestive system. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21144957 (2020).","DOI":"10.3390\/ijms21144957"},{"key":"77727_CR59","first-page":"2963","volume":"8","author":"T Mukhopadhyay","year":"2002","unstructured":"Mukhopadhyay, T., Sasaki, J., Ramesh, R. & Roth, J. A. Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo. Clin. Cancer Res. 8, 2963\u20132969 (2002).","journal-title":"Clin. Cancer Res."},{"key":"77727_CR60","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s00210-023-02722-z","volume":"397","author":"A Aliabadi","year":"2024","unstructured":"Aliabadi, A. et al. In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning. Naunyn-Schmiedebergs Arch. Pharmacol. 397, 2379\u20132388 https:\/\/doi.org\/10.1007\/s00210-023-02722-z (2024).","journal-title":"Naunyn-Schmiedebergs Arch. Pharmacol."},{"key":"77727_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-019-4273-5","volume":"12","author":"K Blom","year":"2019","unstructured":"Blom, K. et al. Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition. BMC Res. Notes 12, 234 https:\/\/doi.org\/10.1186\/s13104-019-4273-5 (2019).","journal-title":"BMC Res. Notes"},{"key":"77727_CR62","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijrobp.2018.08.046","volume":"103","author":"L Zhang","year":"2019","unstructured":"Zhang, L. et al. Mebendazole potentiates radiation therapy in triple-negative breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 103, 195\u2013207 https:\/\/doi.org\/10.1016\/j.ijrobp.2018.08.046 (2019).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"77727_CR63","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/neuonc\/nor077","volume":"13","author":"RY Bai","year":"2011","unstructured":"Bai, R. Y., Staedtke, V., Aprhys, C. M., Gallia, G. L. & Riggins, G. J. Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme. Neuro-Oncol. 13, 974\u2013982 https:\/\/doi.org\/10.1093\/neuonc\/nor077 (2011).","journal-title":"Neuro-Oncol."},{"key":"77727_CR64","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41573-025-01139-y","volume":"24","author":"JS Lorente","year":"2025","unstructured":"Lorente, J. S. et al. GPCR drug discovery: new agents, targets and indications. Nat. Rev. Drug Discov. 24, 458\u2013479 https:\/\/doi.org\/10.1038\/s41573-025-01139-y (2025).","journal-title":"Nat. Rev. Drug Discov."},{"key":"77727_CR65","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.tibs.2023.05.011","volume":"48","author":"A Schlessinger","year":"2023","unstructured":"Schlessinger, A., Zatorski, N., Hutchinson, K. & Colas, C. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities. Trends Biochem. Sci. 48, 801\u2013814 https:\/\/doi.org\/10.1016\/j.tibs.2023.05.011 (2023).","journal-title":"Trends Biochem. Sci."},{"key":"77727_CR66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.apsb.2019.12.006","volume":"10","author":"WX Song","year":"2020","unstructured":"Song, W. X., Li, D. Y., Tao, L., Luo, Q. & Chen, L. G. Solute carrier transporters: the metabolic gatekeepers of immune cells. Acta Pharmaceutica Sin. B 10, 61\u201378 https:\/\/doi.org\/10.1016\/j.apsb.2019.12.006 (2020).","journal-title":"Acta Pharmaceutica Sin. B"},{"key":"77727_CR67","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nmeth.4169","volume":"14","author":"A Punjani","year":"2017","unstructured":"Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290 https:\/\/doi.org\/10.1038\/nmeth.4169 (2017).","journal-title":"Nat. Methods"},{"key":"77727_CR68","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1107\/s0907444910007493","volume":"66","author":"P Emsley","year":"2010","unstructured":"Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. Sect. D.-Biol. Crystallogr. 66, 486\u2013501 https:\/\/doi.org\/10.1107\/s0907444910007493 (2010).","journal-title":"Acta Crystallogr. Sect. D.-Biol. Crystallogr."},{"key":"77727_CR69","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/s2059798318006551","volume":"74","author":"PV Afonine","year":"2018","unstructured":"Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. Sect. D.-Struct. Biol. 74, 531\u2013544 https:\/\/doi.org\/10.1107\/s2059798318006551 (2018).","journal-title":"Acta Crystallogr. Sect. D.-Struct. Biol."},{"key":"77727_CR70","unstructured":"Schrodinger, L. The PyMOL Molecular Graphics System, Version 1. (2015)."},{"key":"77727_CR71","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/pro.3943","volume":"30","author":"EF Pettersen","year":"2021","unstructured":"Pettersen, E. F. et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers. Protein Sci. 30, 70\u201382 https:\/\/doi.org\/10.1002\/pro.3943 (2021).","journal-title":"Protein Sci."},{"key":"77727_CR72","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1002\/jcc.23354","volume":"34","author":"J Huang","year":"2013","unstructured":"Huang, J. & MacKerell, A. D. CHARMM36 all-atom additive protein force field: Validation based on comparison to NMR data. J. Comput. Chem. 34, 2135\u20132145 https:\/\/doi.org\/10.1002\/jcc.23354 (2013).","journal-title":"J. Comput. Chem."},{"key":"77727_CR73","doi-asserted-by":"publisher","unstructured":"Jo, S., Kim, T. & Im, W. Automated Builder and Database of Protein\/Membrane Complexes for Molecular Dynamics Simulations. Plos One 2 https:\/\/doi.org\/10.1371\/journal.pone.0000880 (2007).","DOI":"10.1371\/journal.pone.0000880"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77727-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77727-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77727-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:02:13Z","timestamp":1792062133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77727-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,14]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77727"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77727-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,14]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10799"}}